Hyperbaric Oxygen Therapy Improves Brain Function in Patients With Cognitive Decline After COVID-19 Infection.
The Effects of Hyperbaric Oxygen Therapy on Brain Function in Patients With Cognitive Decline After COVID-19 Infection.
Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
This NA trial investigates COVID-19 and Cognitive Decline and is currently ongoing. The First Affiliated Hospital of Zhejiang Chinese Medical University leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
4 versions recorded-
Mar 2025 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital of Zhejiang Chinese Medical University
For direct contact, visit the study record on ClinicalTrials.gov .